ArticleThe journal of allergy and clinical immunology. In practice2022

COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated.

Nikolaos Lazarinis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.